Atlas Trials

A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea

Clinical trial NCT07235917 · RECRUITING

Trial details

NCT number
NCT07235917
Sponsor
Regeneron Pharmaceuticals
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Functional Hypothalamic Amenorrhea (FHA)
Start date
2026-03-11
Primary completion
2027-08-20
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.